Prot# PX-171-003: An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date11/7/0712/31/13

Funding

  • Proteolix, Inc. (PX-171-003)